BMS 6078 (Metaglip 5 mg / 500 mg)

Generic Name: glipizide/metformin

Pill imprint BMS 6078 has been identified as Metaglip 5 mg / 500 mg.

Metaglip is used in the treatment of diabetes, type 2 and belongs to the drug class antidiabetic combinations. Risk cannot be ruled out during pregnancy. Metaglip 5 mg / 500 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for BMS 6078

Metaglip 5 mg / 500 mg BMS 6078
Metaglip 5 mg / 500 mg BMS 6078 Front
Metaglip 5 mg / 500 mg BMS 6078 Back
Metaglip
Generic Name:
glipizide/metformin
Imprint:
BMS
6078
Strength:
5 mg / 500 mg
Color:
Pink
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Antidiabetic combinations
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Bristol-Myers Squibb
National Drug Code (NDC):
00087-6078
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
54868-5288 Physicians Total Care Inc (repackager)

Note: Inactive ingredients may vary.

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web2)